Hypertrophic Cardiomyopathy Program
Hypertrophic cardiomyopathy (HCM), a complex cardiac disease marked by a thickening of the heart muscle, makes it difficult for the heart to pump blood, forcing it to work harder to get blood throughout the body.
HCM affects people in different ways. Patients may experience shortness of breath, exercise intolerance, chest pressure or pain, fainting or no symptoms at all. Because it doesn’t always cause symptoms, some people with HCM don’t know that they have this disease. As a result, HCM is the leading cause of sudden cardiac death among young athletes and people under 30.
Our HCM Program is led by Mark Sherrid, MD, FACC, FASE, a nationally known expert in the diagnosis and treatment of this disease. To properly diagnosis HCM, our cardiologists use echocardiography or sound wave imaging to photograph the heart and determine the thickness of its muscle. We often perform other follow-up tests to confirm the diagnosis and assess risk.
A patient’s treatment plan depends on the nature and severity of the symptoms, the amount of thickening within the heart and the presence of obstructive or nonobstructive HCM. Treatment options include medications, surgery or implanting a defibrillator. For more information on our HCM Program, please visit the program’s website or contact the following practice site located on Manhattan's Upper West Side:
UMPA Cardiology at 59th Street
425 West 59th Street, Suites 9C & 9D
New York, NY 10019